Cancer patients who use cannabis to address their symptoms have less pain and sleep better, according to new University of Colorado Boulder research. But they also experience another, unexpected, benefit: After a few weeks of sustained use, they seem to think more clearly.
Researcher will discuss the study which involved a sleeping aid known as suvorexant that is already approved by the Food and Drug Administration (FDA) for insomnia, hints at the potential of sleep medications to slow or stop the progression of Alzheimer’s disease.
A study, led by University of Oregon neuroscientist Shawn Lockery, points to worms as a useful tool for understanding more about the many roles that cannabinoids naturally play in the body. And it could help researchers develop better drugs that target this system.
Results of an anonymous cancer patient and survivor survey conducted by a team from Roswell Park Comprehensive Cancer Center’s Center for Translational Research on Cannabis and Cancer (CTRCC) will be shared at the American Association for Cancer Research 2023 Annual Meeting in Orlando.
While legal cannabis products in the United States are required to report THC potency levels on their packaging those levels aren't necessarily accurate, which can have important implications for cannabis consumers. According to a new study from the University of Northern Colorado’s Department of Biological Sciences, researchers Mitchell McGlaughlin and Anna Schwabe found that the THC potency values reported on the packaging of cannabis samples from dispensaries across Colorado’s Front Range are substantially over-reported.
New smart-drug treatment options for pancreatic cancer, immuno-oncology treatments and real-time immune-monitoring strategies are among the research topics to be presented by investigators at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) at the American Association for Cancer Research (AACR) annual meeting held April 14-19 at the Orange County Convention Center in Orlando, Florida.
A majority of Canadians who require medical cannabis are obtaining their products through the recreational market rather than the medical system, raising health and safety concerns, according to a massive new study led by a UM researcher.
The U.S. Department of Justice is supporting the Musah Lab at the University at Albany with a $401,988 grant to develop and validate the test through December 2024.
20240326113011.png&width=400&height=400){kind=logo}
Recordings of media briefings will be posted by 10 a.m. Eastern Time on each day. Watch recorded media briefings at: www.acs.org/ACSSpring2023briefings.
From septic shock to sticker shock. Keep up with this ever-growing, changing sector. Below are some of the latest stories on healthcare on Newswise.
Tammy Chung, director of the Center for Population Behavioral Health at Rutgers Institute for Health, explains cannabis use disorder and the challenges of diagnosing the disorder in the context of cannabis used for therapeutic purposes.
Naloxone can reverse potentially fatal overdoses, but it’s less effective against powerful fentanyl. To develop alternatives, researchers are looking to a component of marijuana, CBD. They will present their results at ACS Spring 2023.
Researchers found recreational cannabis markets were associated with a 10% increase, on average, in motor vehicle accident deaths. The study was conducted using death certificate data to compare mortality rates in states that legalized recreational cannabis dispensaries with states that only provided access to medical cannabis.
Saint Louis University’s Cannabis Science and Operations Certificate program was named the 2023 Outstanding Program by the University Professional and Continuing Education Association (UPCEA). The award recognizes outstanding professional and continuing education programs allowing students to earn academic credit.
In a new study, University of California, Irvine researchers found that exposure to the compound tetrahydrocannabinol (THC), a component of cannabis, at a young age could lead to depleted ovarian follicles and matured eggs in adulthood by nearly 50 percent.
It's sleep awareness week, according to the National Sleep Foundation. It’s important to understand how sleep deprivation can impact your health. Most people recognize that if they don’t get enough sleep, their mood and memory will suffer the next day.
Treatment with an FDA-approved cannabidiol (CBD) oil product does not lower pain scores after surgical treatment and stent placement for patients with urinary stones, reports a clinical trial in the April issue of The Journal of Urology®, an Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.
New findings expand on previous research suggesting that Black newborns are more likely to be screened for prenatal drug exposure compared to other racial and ethnic groups, even in the absence of risk factors for substance use disorders.
Cannabis poisoning is soaring among small children as parents inadvertently leave edibles within their kids’ reach. Our expert explains how to childproof your pot. As marijuana has become legal in more states across the U.S., a recent analysis has found that the drug is accidentally ending up in the hands—and mouths—of children.
In patients who underwent non-cardiac surgery in Boston between 2008 and 2020, those with a diagnosed cannabis use disorder more often required advanced postprocedural healthcare compared to non-users. However, patients whose use of cannabis was not classified as a disorder had lower odds of requiring advanced healthcare after surgery compared to patients who never use cannabis.
Contrary to some common claims, a study led by Johns Hopkins Medicine researchers found that relatively high doses of cannabidiol (CBD) may increase the adverse effects of delta-9-tetrahydrocannabinol (THC), the main active ingredient in cannabis that can cause a mood alteration or a “high” sensation. The findings show that in edible cannabis products, CBD inhibits the metabolism, or breakdown, of THC, which may result in stronger and longer drug effects.
More U.S. high school seniors reported vaping cannabis in states where it is legal only for medical purposes than states where all adult use is permitted – a study finding that surprised the researchers.
There has been a 1,107.01 percent increase in the number of people with medical cannabis cards in Florida (2018 to Jan. 27). One key reason is because many people believe cannabinoids – plant derived, medicinal, and synthetic or chemically engineered – are safe to use. A study shows that 386 people died in Florida as a result of cannabis use; of these, 258 cases were caused by synthetic cannabis. Nearly 88 percent were men; 28 percent of deaths were in those ages 45 to 54, compared to 9 percent in those ages 8 to 24. Nearly 99 percent of individuals using cannabis and synthetic cannabis died from accidents.
The short-term effects of vaporised cannabis do not differ between adolescents and adults, while cannabidiol (CBD) does not dampen the effects of the drug, finds a new study led by UCL and King’s College London researchers.
Despite laws against advertising cannabis to teens, young people reported in surveys that they still see a lot of positive cannabis messages through social media posts.
Below are some of the latest articles that have been added to the Behavioral Science channel on Newswise, a free source for journalists.
Nearly four years ago, federal health officials reported on a frightening new epidemic linked to e-cigarette use that caused a life-threatening and potentially irreversible lung condition.
Young people classified as bisexual not only use cannabis more frequently but also are more likely to use it to cope with mental health issues and for what researchers call experiential “enhancement.”
States that permit recreational use of cannabis see a reduction in demand for prescription codeine, an opioid with a high potential for misuse.
Inspiration strikes when you least expect it. For Wei Jiang, M.D., a professor of Microbiology and Immunology at the Medical University of South Carolina (MUSC), inspiration came in 2018 on a smoke-filled boat tour around Amsterdam during an international conference.
Josee Guindon, DVM, Ph.D., has been named the 2023 William A Devane Young Investigator Award honoree by the International Cannabinoid Research Society.
UC San Diego School of Medicine study shows cannabis-related emergency department visits among older adults are on the rise with high risk for adverse effects of cannabis use for ages 65 and older.
According to a new study published in JAMA Network Open, almost a third of patients with chronic pain reported using cannabis to manage it.
All patients undergoing procedures requiring anesthesia should be asked about cannabis use, according to guidelines released by the American Society of Regional Anesthesia and Pain Medicine (ASRA Pain Medicine). The first U.S. guidelines on cannabis use in relation to surgery also notes regular use may worsen pain and nausea after surgery and increase the need for opioids.
Here are some of the latest articles that have been added to the Behavioral Science channel on Newswise, a free source for journalists.
Adolescent cannabis abuse has increased 245% since 2000 in the US, while alcohol abuse has steadily declined over the same period.
A team of scientists from the National University of Singapore (NUS) has successfully identified the urinary biomarkers of an emerging subclass of synthetic cannabinoids, called OXIZID, to monitor potential abuse.
Pregnant women living in US states where cannabis is legal must be screened for the drug, for the health of both mother and baby, claim scientists who in a new national study have found that they are far more likely to use the substance.
In cannabis trials against pain, people who take placebos report feeling largely the same level of pain relief as those who consume the active cannabinoid substance.
The use of cannabis may have a negative impact on outcomes for a common bypass surgery, a study suggests. Patients who used cannabis prior to lower extremity bypass had decreased patency, meaning the graft had a higher chance of becoming blocked or occluded, higher rate of amputation and opioid use after discharge.
Here are some of the latest articles that have been added to the Arthritis channel on Newswise.
As personal and medical marijuana use increases nationwide, the American Dental Association (ADA) suggests patients refrain from using marijuana before dental visits after a new survey finds more than half of dentists (52%) reported patients arriving for appointments high on marijuana or another drug.
Invitation for emergency medicine symposium
Here are some of the latest articles that have been added to the Drugs and drug abuse channel.
Adults who use cannabis have more pain after surgery than those who don’t use cannabis, according to a study presented at the ANESTHESIOLOGY® 2022 annual meeting.
One is an illegal drug found in marijuana while the other is marketed as a safe herbal alternative.
The latest articles that have been added to the Environmental Health channel.
Patients who are dependent on marijuana may face higher infection rates following knee and shoulder arthroscopy.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
